Literature DB >> 28536732

Pemphigus Vulgaris and Pemphigus Foliaceus: Differences in Epidemiology and Mortality.

Khalaf Kridin1, Shira Zelber-Sagi, Reuven Bergman.   

Abstract

Little is known about differences in epidemiological features and prognosis between pemphigus vulgaris (PV) and pemphigus foliaceus (PF). The objective of this study was to compare PV and PF patients regarding ethnic variations and mortality rates. Mortality of PV and PF patients was compared with age- and sex-matched control subjects in the general population. The study cohort comprised 207 patients with PV and 30 with PF diagnosed during the period 2000 to 2015. The incidence rate of PV among Jews was 3.6-fold higher than among Arabs (p<0.001), whereas no ethnic predisposition to PF was noted (p = 0.379). The risk of death for patients with PV was almost 3-fold higher than in the general population (standardized mortality ratio (SMR) 2.6). For patients with PF, the risk of mortality was not significantly increased relative to the general population (SMR 1.4). There is a racial predisposition to PV, whereas PF is sporadic. Mortality among patients with PV is higher compared with PF and the general population.

Entities:  

Mesh:

Year:  2017        PMID: 28536732     DOI: 10.2340/00015555-2706

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  17 in total

1.  Prevalence of pemphigus in Colombia from 2013 to 2017 according to data from the National Health Registry.

Authors:  Daniel Fernández-Avila; Laura Charry-Anzola; Lina González-Cardona
Journal:  An Bras Dermatol       Date:  2022-05-26       Impact factor: 2.113

2.  Pemphigus Vulgaris: A Clinical Study of 31 Cases (2004-2014) in Morocco.

Authors:  Titou Hicham; Fatima Zahra Chahnoun; Tarik Hanafi; Naoufal Hjira; Boui Mohammed
Journal:  Dermatol Res Pract       Date:  2020-09-08

Review 3.  Pemphigus group: overview, epidemiology, mortality, and comorbidities.

Authors:  Khalaf Kridin
Journal:  Immunol Res       Date:  2018-04       Impact factor: 2.829

4.  Survival of Adjuvant Drugs for Treatment of Pemphigus: A Population-based Cohort Study.

Authors:  Khalaf Kridin; Christoph M Hammers; Ralf J Ludwig; Dana Tzur Bitan; Arnon D Cohen
Journal:  Acta Derm Venereol       Date:  2021-09-03       Impact factor: 3.875

5.  Involvement of Nail Apparatus in Pemphigus Vulgaris in Ethnic Poles Is Infrequent.

Authors:  Pawel Pietkiewicz; Monika Bowszyc-Dmochowska; Justyna Gornowicz-Porowska; Marian Dmochowski
Journal:  Front Med (Lausanne)       Date:  2018-08-14

Review 6.  Pemphigus: Current and Future Therapeutic Strategies.

Authors:  Dario Didona; Roberto Maglie; Rüdiger Eming; Michael Hertl
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

Review 7.  Management of Pemphigus in COVID-19 Pandemic Era; a Review Article.

Authors:  Fahimeh Abdollahimajd; Mohammad Shahidi-Dadras; Reza M Robati; Sahar Dadkhahfar
Journal:  Arch Acad Emerg Med       Date:  2020-04-18

Review 8.  Oral Lesions in Autoimmune Bullous Diseases: An Overview of Clinical Characteristics and Diagnostic Algorithm.

Authors:  Hanan Rashid; Aniek Lamberts; Gilles F H Diercks; Hendri H Pas; Joost M Meijer; Maria C Bolling; Barbara Horváth
Journal:  Am J Clin Dermatol       Date:  2019-12       Impact factor: 7.403

Review 9.  Deep pemphigus (pemphigus vulgaris, pemphigus vegetans and paraneoplastic pemphigus) in dogs, cats and horses: a comprehensive review.

Authors:  Heng L Tham; Keith E Linder; Thierry Olivry
Journal:  BMC Vet Res       Date:  2020-11-23       Impact factor: 2.741

Review 10.  Emerging treatment options for the management of pemphigus vulgaris.

Authors:  Khalaf Kridin
Journal:  Ther Clin Risk Manag       Date:  2018-04-27       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.